Cresset Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.04M | Buy |
2,716
+1,239
| +84% | +$475K | ﹤0.01% | 758 |
|
2025
Q1 | $510K | Sell |
1,477
-71
| -5% | -$24.5K | ﹤0.01% | 1049 |
|
2024
Q4 | $465K | Sell |
1,548
-12,778
| -89% | -$3.84M | ﹤0.01% | 1104 |
|
2024
Q3 | $5.82M | Buy |
14,326
+2,465
| +21% | +$1M | 0.02% | 412 |
|
2024
Q2 | $3.81M | Buy |
11,861
+2,787
| +31% | +$895K | 0.02% | 474 |
|
2024
Q1 | $3.03M | Buy |
9,074
+744
| +9% | +$248K | 0.01% | 475 |
|
2023
Q4 | $2.25M | Sell |
8,330
-3,042
| -27% | -$823K | 0.01% | 531 |
|
2023
Q3 | $2.8M | Buy |
11,372
+149
| +1% | +$36.7K | 0.01% | 424 |
|
2023
Q2 | $3.41M | Buy |
11,223
+10,206
| +1,004% | +$3.1M | ﹤0.01% | 383 |
|
2023
Q1 | $268K | Sell |
1,017
-3
| -0.3% | -$791 | 0.01% | 667 |
|
2022
Q4 | $236K | Sell |
1,020
-181
| -15% | -$41.9K | ﹤0.01% | 606 |
|
2022
Q3 | $222K | Hold |
1,201
| – | – | ﹤0.01% | 765 |
|
2022
Q2 | $200K | Sell |
1,201
-1,965
| -62% | -$327K | ﹤0.01% | 840 |
|
2022
Q1 | $794K | Sell |
3,166
-202
| -6% | -$50.7K | 0.01% | 464 |
|
2021
Q4 | $865K | Sell |
3,368
-1,419
| -30% | -$364K | 0.01% | 503 |
|
2021
Q3 | $1.16M | Buy |
4,787
+988
| +26% | +$240K | 0.02% | 346 |
|
2021
Q2 | $785K | Buy |
3,799
+284
| +8% | +$58.7K | 0.01% | 420 |
|
2021
Q1 | $662K | Buy |
3,515
+909
| +35% | +$171K | 0.01% | 396 |
|
2020
Q4 | $429K | Sell |
2,606
-70
| -3% | -$11.5K | 0.01% | 438 |
|
2020
Q3 | $334K | Sell |
2,676
-182
| -6% | -$22.7K | 0.01% | 476 |
|
2020
Q2 | $282K | Sell |
2,858
-39
| -1% | -$3.85K | 0.01% | 486 |
|
2020
Q1 | $260K | Buy |
2,897
+96
| +3% | +$8.62K | 0.01% | 439 |
|
2019
Q4 | $414K | Buy |
2,801
+689
| +33% | +$102K | 0.01% | 339 |
|
2019
Q3 | $254K | Buy |
2,112
+147
| +7% | +$17.7K | 0.01% | 429 |
|
2019
Q2 | $266K | Sell |
1,965
-1,115
| -36% | -$151K | 0.01% | 362 |
|
2019
Q1 | $402K | Buy |
3,080
+2,861
| +1,306% | +$373K | 0.02% | 217 |
|
2018
Q4 | $27K | Buy |
+219
| New | +$27K | ﹤0.01% | 651 |
|